Sarikaya Ismet, Sarikaya Ali, Albatineh Ahmed N, Tastekin Ebru, Sezer Yavuz Atakan
Faculty of Medicine, Department of Nuclear Medicine, Kuwait University and Mubarak Al-Kabeer Hospital, Kuwait.
Faculty of Medicine, Department of Nuclear Medicine, Trakya University, Edirne, Turkey.
Asia Ocean J Nucl Med Biol. 2020 Winter;8(1):27-35. doi: 10.22038/aojnmb.2019.41658.1284.
Studies have reported that invasive ductal carcinoma (IDC) with coexisting ductal carcinoma in situ (DCIS) show lower metastatic potential and recurrence and better overall survival than pure IDC. In this study, we assessed F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images of patients with newly diagnosed IDC to determine if there is any difference in PET findings in IDC-DCIS and pure IDC cases.
FDG PET/CT images of patients with newly diagnosed IDC of the breast who subsequently underwent breast surgery and had histopathology result in our records were further evaluated. Tumor grade, pathological staging, and presence of DCIS were noted from the histopathology results. Standardized uptake value (SUV) of the primary tumor (SUV and SUL), other hypermetabolic foci in the breast, and ipsilateral normal breast were measured. Presence of axillary and distant metastases was noted.
Fifty seven (57) patients with IDC were included. Coexisting DCIS was present in 44 (IDC-DCIS) and not present in 13 (pure IDC) cases. Per histopathology, the primary tumor was unifocal in 33 IDC-DCIS (75%) and 12 pure IDC (92.3%) cases, and multifocal in 11 IDC-DCIS cases (25%), and 1 pure IDC case (7.7%). FDG uptake was multifocal in 20 IDC-DCIS cases (45.5%) and 1 pure IDC case (7.7%), and unifocal in 24 IDC-DCIS (54.5%), and 12 pure IDC (92.3%) cases. There was no significant difference in patient age, size of the primary tumor, SUV and SUL of the primary tumor and SUV of the normal breast in IDC-DCIS and pure IDC cases (p>0.05). Pathology showed axillary metastasis in all 13 pure IDC (100%), and 27 IDC-DCIS (61.4%) cases. PET showed axillary uptake in 25 IDC-DCIS (56.8%), and 8 pure IDC (61.5%) cases, and abnormal/questionable distant uptake in 12 IDC-DCIS cases and 1 pure IDC case.
In our preliminary findings, multifocal breast FDG uptake and multifocal tumor appear to be more common in IDC-DCIS than pure IDC. There is no significant difference in SUV and size of the primary tumor in IDC-DCIS and pure IDC cases. Axillary metastases appear to be more common in pure IDC than IDC-DCIS cases.
研究报告称,伴有原位导管癌(DCIS)的浸润性导管癌(IDC)相较于单纯IDC,转移潜能和复发率更低,总体生存率更高。在本研究中,我们评估了新诊断为IDC患者的F-18氟脱氧葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)图像,以确定IDC-DCIS和单纯IDC病例在PET表现上是否存在差异。
对新诊断为乳腺IDC且随后接受乳腺手术并在我们记录中有组织病理学结果的患者的FDG PET/CT图像进行进一步评估。从组织病理学结果中记录肿瘤分级、病理分期和DCIS的存在情况。测量原发肿瘤的标准化摄取值(SUV)(SUV和SUL)、乳腺中的其他高代谢灶以及同侧正常乳腺。记录腋窝和远处转移的存在情况。
纳入了57例IDC患者。44例(IDC-DCIS)存在共存的DCIS,13例(单纯IDC)不存在。根据组织病理学,33例IDC-DCIS(75%)和12例单纯IDC(92.3%)病例的原发肿瘤为单灶性,11例IDC-DCIS病例(25%)和1例单纯IDC病例(7.7%)为多灶性。20例IDC-DCIS病例(45.5%)和1例单纯IDC病例(7.7%)的FDG摄取为多灶性,24例IDC-DCIS(54.5%)和12例单纯IDC(92.3%)病例为单灶性。IDC-DCIS和单纯IDC病例在患者年龄、原发肿瘤大小、原发肿瘤的SUV和SUL以及正常乳腺的SUV方面无显著差异(p>0.05)。病理显示,所有13例单纯IDC(100%)和27例IDC-DCIS(61.4%)病例有腋窝转移。PET显示,25例IDC-DCIS(56.8%)和8例单纯IDC(61.5%)病例有腋窝摄取,12例IDC-DCIS病例和1例单纯IDC病例有异常/可疑的远处摄取。
在我们的初步研究结果中,乳腺FDG摄取多灶性和肿瘤多灶性在IDC-DCIS中似乎比单纯IDC更常见。IDC-DCIS和单纯IDC病例在原发肿瘤的SUV和大小方面无显著差异。腋窝转移在单纯IDC中似乎比IDC-DCIS病例更常见。